论文部分内容阅读
目的观察杞枣口服液治疗儿童高血铅的临床疗效。方法选择96例年龄3～15岁,血铅100～199μg/L的儿童,随机分为治疗组与对照组各48例,治疗组口服浙江泰利森药业有限公司生产的杞枣口服液每次10ml,2次/d。对照组口服哈药集团生产的钙加锌口服液每次10ml,2次/d,均4周为一疗程,疗程结束后观察患儿症状改善的情况及检测血铅含量。结果治疗组高血铅儿童症状明显改善,血铅含量下降显著,总有效率(91.7%)明显优于对照组(75.%),P<0.05。结论杞枣口服液治疗儿童高血铅的疗效好,不良反应少。
Objective To observe the clinical efficacy of Qizao oral liquid in treating high blood lead in children. Methods Ninety-six children aged 3-15 years and 100 ~ 199μg / L of blood lead were randomly divided into treatment group (48 cases) and control group (48 cases). The treatment group was orally administered with Qi Zhai oral liquid produced by Zhejiang Talisen Pharmaceutical Co., Ltd. 10ml, 2 times / d. The control group oral administration of calcium and zinc oral solution produced by the Harbin Pharmaceutical Group 10ml, 2 times / d, were 4 weeks for a course of treatment, after treatment to observe the symptoms of children with improvement and detection of blood lead levels. Results The symptoms of hyperlipidemia children in the treatment group were significantly improved, and the blood lead level decreased significantly. The total effective rate (91.7%) was significantly better than that of the control group (75%), P <0.05. Conclusion Qi jujube oral lead in children with good curative effect, less adverse reactions.